2 results match your criteria: "Shenyang Fourth People Hospital[Affiliation]"
Advances in cancer diagnosis and therapy by alginate-based multifunctional hydrogels: A review.
Int J Biol Macromol
December 2024
Department of Clinical Nutrition, Shengjing Hospital of China Medical University, Shenyang 110004, China. Electronic address:
Article Synopsis
- * Alginate hydrogels enable targeted drug delivery, reducing side effects while increasing the anti-cancer effects and protecting therapeutic genes from degradation.
- * These hydrogels can also respond to stimuli in the tumor environment to release drugs more effectively and support advanced therapies like immunotherapy and phototherapy.
Topical injection of sclerosant to treat cheek subcutaneous venous malformation resulting in blindness: a case report.
BMC Ophthalmol
September 2023
Department of Ophthalmology, Shenyang Fourth People Hospital, Liaoning, China.
Loss of vision after topical injection of sclerosant is a rare and uncommon complication. We describe a case with vision loss following the facial injections of physician-compounded (PCP) foam sclerotherapy which was created by room air. A 3-year-old boy underwent injection of 5ml polidocanol foamed with room air to treat the venous malformation on the cheek near the left orbit.
View Article and Find Full Text PDF